Evaluation of Treosulfan Pharmacokinetics (PK) in Children Undergoing Allogeneic Haematopoietic Stem Cell Transplantation (HSCT)
Phase of Trial: Phase IV
Latest Information Update: 06 Sep 2019
Price : $35 *
At a glance
- Drugs Treosulfan (Primary)
- Indications Transplant rejection
- Focus Pharmacokinetics
- Acronyms TreoPK
- 03 Feb 2019 Status changed to completed.
- 24 Oct 2014 According to the ClinicalTrials.gov record, status changed from not yet recruiting to recruiting.
- 05 Mar 2014 New trial record